Wegovy was approved by the U.S. health regulator last month for lowering the risk of stroke and heart attack in overweight or obese adults who do not have diabetes. The additional approval would expand Medicare coverage for Wegovy and coverage by other insurers for such adults with heart conditions.
About 3.6 million overweight or obese patients with heart conditions insured under the U.S. Medicare program could be eligible for coverage of Novo Nordisk's weight-loss.
3 6 Million Could Qualify for Wegovy Under Medicare newsmax.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newsmax.com Daily Mail and Mail on Sunday newspapers.
Health News Roundup: US Supreme Court split over Idaho s strict abortion ban in medical emergencies; Congo Republic declares mpox epidemic and more devdiscourse.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from devdiscourse.com Daily Mail and Mail on Sunday newspapers.